Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us
Conference Highlights
Connective Tissue Oncology Society (CTOS)
CTOS 2016
CTOS 2016
Randomized Phase 3, Multicenter, Open-Label Study Comparing Evofosfamide (EVO) in Combination with Doxorubicin (D) versus D Alone in Patients with Advanced Soft-Tissue Sarcoma (STS): Study TH-CR-406/SARC021
CTOS 2016
Read More ›
Prognosis of Patients Receiving First-Line Chemotherapy for Advanced Soft-Tissue Sarcomas (STSs) with Locally Advanced vs Distant Metastasis vs Both: An EORTC-STBSG Database Analysis
CTOS 2016
Read More ›
Real-Life Clinical Outcomes of Pazopanib Treatment in Patients with STS: A Japanese Musculoskeletal Oncology Group Study
CTOS 2016
Read More ›
AXI-STS: A UK NCRI Sarcoma Clinical Studies Group Phase 2 Trial of Axitinib in Advanced STS
CTOS 2016
Read More ›
Safety Profile of Trabectedin in Patients with Advanced Soft-Tissue Sarcoma (STS) Who Relapsed after Chemotherapy: Global Expanded Access Program Data
CTOS 2016
Read More ›
Trabectedin Combined with Nivolumab in Advanced STS
CTOS 2016
Read More ›
Trabectedin in Patients with Advanced Soft-Tissue Sarcoma (STS) Who Are Unfit for Standard Chemotherapy
CTOS 2016
Read More ›
TRC105 (Endoglin Antibody) in Combination with Pazopanib in Patients with Advanced Angiosarcoma
CTOS 2016
Read More ›
Meta-Analysis of Pazopanib versus Other Antiangiogenic Tyrosine Kinase Inhibitors (TKIs) in Advanced STS
CTOS 2016
Read More ›
Pembrolizumab in Advanced Soft-Tissue Sarcomas (STS)
CTOS 2016
Read More ›
Page 1 of 2
1
2
Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us